In cancer cells, TGF-β signaling can activate the PI3K-Akt pathway either directly or indirectly, to increase PIP2 and PIP3 to recruit proteins with lipid-binding domains to the plasma membrane [59]. This evidence concerns the gene AKT1 and cancer.